Chelsea Therapeutics International Target of Unusually High Options Trading (CHTP)
Chelsea Therapeutics International (NASDAQ:CHTP) saw some unusual options trading activity on Friday. Traders acquired 22,280 put options on the stock, AnalystRatings.NET reports. This represents an increase of approximately 621% compared to the typical volume of 3,090 put options.
A number of analysts have recently weighed in on CHTP shares. Analysts at Ladenburg Thalmann cut their price target on shares of Chelsea Therapeutics International from $4.00 to $3.00 in a research note to investors on Friday. They now have a “buy” rating on the stock. Separately, analysts at Wedbush reiterated an “outperform” rating on shares of Chelsea Therapeutics International in a research note to investors on Friday. Finally, analysts at JMP Securities initiated coverage on shares of Chelsea Therapeutics International in a research note to investors on Thursday, December 19th. They set an “outperform” rating and a $8.00 price target on the stock. Five analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and an average target price of $5.50.
Shares of Chelsea Therapeutics International (NASDAQ:CHTP) traded down 29.18% on Friday, hitting $2.50. The stock had a trading volume of 18,915,464 shares. Chelsea Therapeutics International has a one year low of $0.76 and a one year high of $4.53. The stock’s 50-day moving average is $3.82 and its 200-day moving average is $3.10. The company’s market cap is $176.9 million.
Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.